completed

The objective of the ACTIVE A study was to determine the efficacy of clopidogrel plus ASA versus ASA alone in patients with atrial fibrillation (AF), and with at least one risk factor for stroke who have a contraindication for other oral anticoagulation.

Composite outcome:

Stroke, non-CNS systemic embolism, myocardial infarction, or vascular death.

Study Type

Interventional - Drug

Study Design

Double-blind, placebo controlled superiority RCT

NO. of Countries

33

NO. of Sites

633

NO. of Participants

7554

Study Period

2003 - 2008

Sponsor

Sanofi

Bristol-Myers Squibb

Sanofi

Back To Top